Joint models in both directions and at scale: jmBIG and JMbdirect for dynamic prediction
Longitudinal biomarkers and time-to-event outcomes that act on each other, fitted on cohorts of any size
Atanu Bhattacharjee
Time-to-event data: the building blocks
Event times are right-censored; survival is described by the survival curve or the hazard, estimated by Kaplan–Meier and related to covariates by Cox regression.
Censoring
Follow-up may end before the event; we observe the earlier time and which one it was. Censoring is assumed non-informative.
Survival and hazard
Share still event-free, and the instantaneous event rate among those at risk.
Kaplan–Meier
Product of conditional survival over event times; nⱼ at risk, dⱼ events at tⱼ.
Cox proportional hazards
Covariates act multiplicatively on an unspecified baseline hazard; β by partial likelihood, hazard ratio exp(β).
Kaplan EL, Meier P. JASA 1958; 53: 457–481. Cox DR. J R Stat Soc B 1972; 34: 187–220.
Longitudinal data: mixed models and dropout
Repeated measurements are correlated within a person, irregularly timed and measured with error; the linear mixed model separates the population trajectory from each person's deviation.
Yᵢ(t) = Xᵢ(t)ᵀβ + Zᵢ(t)ᵀbᵢ + εᵢ(t), bᵢ ~ N(0, D), εᵢ(t) ~ N(0, σ²)
Fixed and random effects
β: population trajectory. bᵢ: person-specific intercept and slope; D induces the within-person correlation. σ²: measurement error.
Missing at random
Dropout depends only on observed values: likelihood inference from the mixed model stays valid.
Missing not at random
Dropout depends on the unobserved trajectory, typically because the event itself ends follow-up. The mixed model alone is biased; selection, pattern-mixture or shared-parameter (joint) models are needed.
Laird NM, Ware JH. Biometrics 1982; 38: 963–974. Rubin DB. Biometrika 1976; 63: 581–592. Diggle P, Kenward MG. Appl Stat 1994; 43: 49–93.
Time-varying covariates in the Cox model, and their limits
The extended Cox model uses the covariate value at each event time. That is valid for external covariates; a biomarker measured on the patient is internal, error-prone and observed only at visits.
Value known at every event time
In practice the last observation is carried forward between visits.
No measurement error
Plugging in noisy values attenuates the association towards zero (Prentice 1982).
An external covariate
An internal marker exists only while the patient is event-free, so its path carries information about the event.
hᵢ(t) = h₀(t) exp{ γᵀwᵢ + α yᵢ(t) }, yᵢ(t): observed covariate value at t
Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data, 2nd ed. Wiley 2002. Prentice RL. Biometrika 1982; 69: 331–342.
Four ways to use repeated measurements
| Approach | How the marker enters | Measurement error | Informative dropout |
|---|---|---|---|
| Time-dependent Cox | Last observed value carried forward | Ignored | Ignored |
| Two-stage | Fitted trajectory from a mixed model, plugged into a Cox model | Partly removed | Ignored |
| Landmarking | Value at landmark time t, Cox model fitted on those still at risk | Ignored | Conditioned on survival to t |
| Joint model | Longitudinal and survival submodels share random effects bᵢ | Modelled | Modelled |
Joint modelling fits the marker and the event in one likelihood, so the trajectory, its uncertainty and the dropout it causes are estimated together.
Informative dropout: measurements stop because of the event or the patient's state, so the missing values are related to the outcome.
Why joint modelling matters
Fitting the marker and the event together, in one model, answers what each separate analysis gets wrong.
Less bias in the marker–event association
The true trajectory, not its noisy measurements, enters the event model.
Correct marker trajectories
Dropout caused by the event is modelled, so the trajectory is not distorted by who remains.
Efficiency
Both outcomes inform the shared parameters, so treatment effects on each are estimated more precisely.
Individual prediction
A patient's own measurements update their own risk as follow-up continues.
Hickey GL et al. BMC Med Res Methodol 2016; 16: 117. Alsefri M et al. BMC Med Res Methodol 2020; 20: 94. Wang JL, Zhong Q. Annual Review of Statistics and Its Application 2025; 12.
How joint models began
In the 1990s, AIDS and cancer studies needed to link repeatedly measured markers, such as CD4 counts, to survival. A few papers built the idea of fitting the two together.
DeGruttola V, Tu XM. Biometrics 1994; 50: 1003–1014. Faucett CL, Thomas DC. Statistics in Medicine 1996; 15: 1663–1685. Wulfsohn MS, Tsiatis AA. Biometrics 1997; 53: 330–339. Henderson R, Diggle P, Dobson A. Biostatistics 2000; 1: 465–480. Tsiatis AA, Davidian M. Statistica Sinica 2004; 14: 809–834.
The joint model: two models that share the patient
One model follows how each patient's marker changes over time. A second model describes the risk of the event. Both share the patient's own deviation from the average, so a patient whose marker runs high also carries the matching risk.
Yᵢ(t) = mᵢ(t) + εᵢ(t), mᵢ(t) = Xᵢ(t)ᵀβ + Zᵢ(t)ᵀbᵢ
hᵢ(t) = h₀(t) exp{ Wᵢᵀγ + α mᵢ(t) }
Yᵢ(t) observed marker, mᵢ(t) true marker, bᵢ random effects, εᵢ(t) measurement error, hᵢ(t) event hazard, α association: log hazard ratio per unit of the true marker.
What feature of the marker drives risk?
The link between marker and event is a clinical question: is it the level today, how fast it is changing, how much has built up, or how far the patient sits from the average?
Current value
Risk depends on the true level of the marker now.
α mᵢ(t)
Current slope
Risk also depends on how fast the marker is changing.
α₁ mᵢ(t) + α₂ mᵢ′(t)
Cumulative effect
Risk depends on accumulated exposure, the area under the trajectory.
α ∫₀ᵗ mᵢ(s) ds
Patient deviation
Risk depends on the patient's own departure from the average level and slope.
αᵀbᵢ
Each term enters the event model as hᵢ(t) = h₀(t) exp{ Wᵢᵀγ + term }, a straight-line effect on the log-hazard scale.
Fitting a joint model
The random effects are never observed, so the likelihood averages over every value they could take. Two families of methods do this.
Maximum likelihood (EM)
Treat the random effects as missing data: fill them in from their expected values given the data, update the parameters, repeat. The integral is approximated by Gauss–Hermite quadrature or Laplace approximation.
Wulfsohn & Tsiatis 1997; Rizopoulos 2012.
Bayesian (MCMC)
Place priors on all parameters and draw random effects and parameters together by Markov chain Monte Carlo; uncertainty in predictions comes directly from the draws.
Faucett & Thomas 1996; Ibrahim, Chen & Sinha 2004.
L(θ) = Πᵢ ∫ p(Yᵢ | bᵢ; θ) p(Tᵢ, δᵢ | bᵢ; θ) p(bᵢ; θ) dbᵢ
θ: all parameters; the marker and event contributions are independent given the patient's random effects bᵢ.
Extensions and software
After 2000 the single-marker, single-event model grew towards the data clinicians hold, and software made it routine.
Brown ER et al. Biometrics 2005; 61: 64–73. Chi YY, Ibrahim JG. Biometrics 2006; 62: 432–445. Elashoff RM et al. Stat Med 2007; 26: 2813–2835. Proust-Lima C et al. Stat Methods Med Res 2014; 23: 74–90. Rizopoulos D. J Stat Softw 2010; 35(9): 1–33; J Stat Softw 2016; 72(7): 1–46. Hickey GL et al. BMC Med Res Methodol 2018; 18: 50. Li S et al. Comput Math Methods Med 2022; 1362913.
Three open issues in joint modelling
Three assumptions of the standard joint model limit its use in routinely collected multimorbidity data. My two pieces of work address them.
1. Scale
Fitting is slow; joint models have mostly been used in small to moderate studies, while health records hold hundreds of thousands of patients.
2. One direction
The marker drives the risk of the event, but events never change the marker that follows.
3. A straight-line link
Each unit of the marker adds the same amount of log-risk, so thresholds and plateaus are missed.
jmBIG (2024) → issue 1
Bayesian joint models fitted on patient subsets and combined.
JMbdirect (2026) → issues 2 and 3
Feedback from events to the marker, and flexible spline or neural links between marker and risk.
Li S et al. Comput Math Methods Med 2022; Bhattacharjee A et al. BMC Med Res Methodol 2024; 24: 172; Bhattacharjee A. BMC Med Res Methodol 2026; 26: 230.
Contribution 1: jmBIG solves the scale problem
jmBIG: enhancing dynamic risk prediction and personalized medicine through joint modeling of longitudinal and survival data in big routinely collected data
Bhattacharjee A, Rajbongshi BK, Vishwakarma GK.
Existing issue
Joint models carry a heavy computational burden. Efficient implementation has lagged behind the methods, so in practice they were fitted only to small and moderate studies, never to whole health-record cohorts.
What jmBIG does
Splits the cohort into patient subsets, keeping each patient's visits with their own event record, fits the Bayesian joint model to each subset in parallel and combines the estimates into one model for prediction.
What it achieved
Joint models fitted to a million patients in under an hour on a standard workstation and inside a trusted research environment, with dynamic predictions and model checks from the same fit.
Bhattacharjee A, Rajbongshi BK, Vishwakarma GK. BMC Med Res Methodol 2024; 24: 172. Computational burden as the barrier: Li S et al. Comput Math Methods Med 2022; 1362913; Papageorgiou G et al. Annu Rev Stat Appl 2019; 6: 223–240.
At scale: joint models on routinely collected data
Health-record data bring volume, heterogeneity and computational cost. jmBIG splits the patients into subsets, keeps each patient's longitudinal records with their survival record, fits the joint model to every subset and combines the estimates.
θ̄ = (1/S) Σₛ θ̂ₛ, SE(θ̄) = (1/S) Σₛ SE(θ̂ₛ)
Bayesian routes: posterior means and standard errors averaged across the S subsets. Likelihood route: coefficients and Hessian updated from all subsets together.
Volume, heterogeneity and computational cost of health-record data, and the subset estimation: Bhattacharjee A, Rajbongshi BK, Vishwakarma GK. jmBIG. BMC Med Res Methodol 2024; 24: 172. Efficient implementation has lagged behind, limiting joint models to small and moderate studies: Li S et al. Comput Math Methods Med 2022; 1362913.
How the data are linked, split and merged
A joint model reads two files: many rows per patient for the marker, one row per patient for the event, linked by the patient identifier. jmBIG splits by patient, so each subset keeps every row of its patients, and merges the subset estimates.
θ̄ = (1/S) Σₛ θ̂ₛ
Bayesian routes: posterior means and standard errors averaged across subsets. Likelihood route: coefficients and Hessian updated from all subsets. A patient's rows are never split across subsets.
Bhattacharjee A, Rajbongshi BK, Vishwakarma GK. BMC Med Res Methodol 2024; 24: 172.
One million patients in under an hour
● Bayesian MCMC (JMbayes2 engine)
■ Semiparametric EM (FastJM engine)
▲ Likelihood EM (joineRML engine)
◆ Bayesian HMC (Stan engine)
Processing time in minutes by number of patients (log scale); values at 1,000,000 patients labelled. A cohort of 1,000 patients with repeated visits and time to death took 2.3, 1.2, 1.2 and 2.72 minutes respectively. Source: Bhattacharjee, Rajbongshi and Vishwakarma, BMC Med Res Methodol 2024;24:172, Table 1.
Issue 2 in practice: conditions that drive each other
Scale
Routinely collected health records hold repeated biomarker measurements on hundreds of thousands to millions of patients.
Direction
A cardiovascular event can permanently shift the glycaemic trajectory; a first cardiovascular hospitalisation accelerates eGFR decline.
Prediction
Risk for each patient has to update as new biomarker values and new events arrive.
Bidirectional diabetes–CVD–CKD relations as motivation: Bhattacharjee A. BMC Med Res Methodol 2026; 26: 230.
Contribution 2: JMbdirect solves direction and shape
JMbdirect: joint modeling with semiparametric link functions for bidirectional feedback in longitudinal-survival data
Bhattacharjee A.
Issue 2 · influence runs one way
Before: the marker drives the hazard, but an event never changes the marker that follows.
Solved by: explicit feedback terms, a level shift κ₀ and a slope change κ₁ in the marker after each event.
Issue 3 · a straight-line link
Before: each unit of the marker adds the same log-risk, so thresholds and plateaus are missed.
Solved by: semiparametric links, penalised splines or neural additive components, keeping a likelihood and uncertainty bands.
What it showed
Feedback recovered with negligible bias. Feedback with a flexible link gave better discrimination and calibration than linear, one-direction joint models, with near-nominal coverage.
Fitted by penalised likelihood (Laplace) or Bayesian HMC.
Bhattacharjee A. BMC Med Res Methodol 2026; 26: 230. Linear, one-direction formulation: Wulfsohn MS, Tsiatis AA. Biometrics 1997; 53: 330–339; Rizopoulos D. CRC Press 2012.
From one direction to both directions
Two changes to the standard model: the link between marker and risk is allowed to bend, and events that happen along the way change the marker that follows.
Standard one-direction model: Wulfsohn MS, Tsiatis AA. Biometrics 1997; 53: 330–339. Bidirectional model: Bhattacharjee A. JMbdirect. BMC Med Res Methodol 2026; 26: 230.
Feedback: each event moves the marker's level and slope
Some events change the marker that follows: a cardiovascular event can shift HbA1c for good, and cancer recurrence makes CA-125 jump.
Level shift and slope change
An immediate jump once the event has happened, and faster or slower progression afterwards.
Clinical scale
CA-125 after ovarian cancer recurrence; eGFR decline after a first cardiovascular hospitalisation.
What the data must show
At least one measurement after the event for the jump, two for the slope; about five per event type across the cohort.
mᵢ(t) = Xᵢ(t)ᵀβ + Zᵢ(t)ᵀbᵢ + Σj ∈ Jᵢ(t) { κⱼ₀ I(t ≥ Tᵢⱼ) + κⱼ₁ (t − Tᵢⱼ)₊ }
Feedback specification: Bhattacharjee A. BMC Med Res Methodol 2026; 26: 230.
Try it: an event that changes the marker
Move the sliders. A non-terminal event at time T shifts the marker's level and slope; the risk of the terminal event follows the new path.
Dashed: path and risk if the event had no effect on the marker. Solid: with feedback.
Illustration of the JMbdirect feedback term
Risk does not always rise in a straight line
The standard model assumes each unit of the marker adds the same amount of log-risk. Real risk often has a threshold or a plateau. Replacing the straight line with a smooth curve lets the data show the shape.
Smooth spline curve
Built from many small pieces joined smoothly; a penalty stops it from wiggling more than the data support.
Neural additive curve
A sum of S-shaped steps that can capture sharp thresholds, kept in check by a penalty.
hᵢₖ(t) = h₀ₖ(t) exp{ Wᵢᵀγₖ + fₖ(mᵢ(t)) }
fₖ(m) = Σₗ αₗ Bₗ(m) or Σq σ(aq m + bq)
Semiparametric links: Bhattacharjee A. BMC Med Res Methodol 2026; 26: 230.
Try it: the shape of the link between marker and risk
Switch between a straight-line link and a flexible link with a threshold. The same marker values give very different hazard ratios.
Hover over the curve to read the hazard ratio against a marker value of 1.
Illustration of linear versus spline links
What the simulations show
Allowing feedback and a flexible link gave the sharpest and best-calibrated predictions, ahead of the established joint models; the gain grows with sample size and with the strength of feedback.
Sharper ranking of patients
Highest discrimination of the six models compared.
Ahead of established joint models
Gains grow
More patients and stronger feedback widen the advantage; a straight-line model does not catch up with more data.
Simulation with competing risks and informative dropout; full figures in the backup slides. Source: Bhattacharjee A. BMC Med Res Methodol 2026; 26: 230.
From one disease to a network of morbidities
In a patient with several conditions, each risk depends on several markers, and an event in one condition can change the markers of another.
Shared risk
The risk of each condition depends on the current state of every marker, not its own alone.
Spillover
An event in one condition shifts the marker of another: renal decline after stroke, systemic markers after cancer recurrence.
Prediction
Each patient's risk for each condition, carrying the effect of every earlier event.
hᵢₘ(t) = h₀ₘ(t) exp{ Wᵢᵀγₘ + fₘ( mᵢ₁(t), …, mᵢM(t) ) }
m*ᵢₖ(t) = mᵢₖ(t) + κⱼₖ₀ I(t ≥ Tᵢⱼ) + κⱼₖ₁ (t − Tᵢⱼ)₊ , k ≠ j
Extension of Bhattacharjee A. BMC Med Res Methodol 2026; 26: 230 and Bhattacharjee A et al. BMC Med Res Methodol 2024; 24: 172; multivariate joint models: Hickey GL et al. BMC Med Res Methodol 2016; 16: 117.
How the two frameworks fit together
Why separate estimation
Feedback terms and flexible links need each patient's whole trajectory, which cannot be split across data shards; they use their own routines: splines in the M-step, neural-component optimisation and feedback-augmented trajectory updates.
One workflow
The same model specification routes to the partitioned pathway when the cohort is large, with predictions returned in the same form.
Bhattacharjee A, Rajbongshi BK, Vishwakarma GK. BMC Med Res Methodol 2024; 24: 172. Bhattacharjee A. BMC Med Res Methodol 2026; 26: 230.
Open issues and how they were solved
Each limitation of the standard joint model, the published work that removes it, and the evidence.
| Open issue | Standard joint model | Solution | Published in |
|---|---|---|---|
| 1. Scale | Slow to fit; limited to small and moderate studies | Subset-and-combine Bayesian estimation in parallel; a million patients in under an hour | Bhattacharjee, Rajbongshi, Vishwakarma. BMC Med Res Methodol 2024; 24: 172 |
| 2. One direction | Events never change the marker path | Post-event level shift κ₀ and slope change κ₁, estimated jointly | Bhattacharjee. BMC Med Res Methodol 2026; 26: 230 |
| 3. Straight-line link | Constant log-risk per unit of marker | Penalised-spline and neural additive links with uncertainty bands | Bhattacharjee. BMC Med Res Methodol 2026; 26: 230 |
| Combined workflow | Large-cohort and flexible models fitted with different tools | Same model specification routes to the partitioned pathway for large cohorts | Bhattacharjee 2024; Bhattacharjee 2026 |
| Result for prediction | Risks pulled to the middle when feedback or non-linearity is present | Sharper and better-calibrated dynamic predictions, at health-record scale | Bhattacharjee 2026 (simulation, competing risks) |
Full references: Bhattacharjee A, Rajbongshi BK, Vishwakarma GK. jmBIG. BMC Med Res Methodol 2024; 24: 172. Bhattacharjee A. JMbdirect. BMC Med Res Methodol 2026; 26: 230.
Dynamic prediction updates with every visit
At each clinic visit, the patient's own measurements so far update their chance of staying event-free over the coming years.
Landmark t, horizon u
The prediction is made at time t, using everything recorded so far, for the window from t to u.
Every measurement counts
The whole marker history to t enters through the patient's random effects, with its uncertainty.
Updates at each visit
A new value changes the random effects and so the whole predicted curve.
πᵢ(u | t) = Pr(Tᵢ > u | Tᵢ > t, Dᵢ(t)) = ∫ Pr(Tᵢ > u | Tᵢ > t, bᵢ) p(bᵢ | Dᵢ(t)) dbᵢ, Dᵢ(t): data up to t
Try it: a prediction that updates at every visit
Add the patient's visits one at a time. Each new value updates the patient's own trajectory and the predicted chance of staying event-free over the next five years.
Grey dashed: population average. Blue: this patient's fitted trajectory. Orange: event-free probability from the latest visit; earlier predictions fade.
Illustration: random-intercept-and-slope model, shrinkage update
Why joint models for dynamic prediction
A dynamic prediction needs the patient's whole marker history, corrected for noise, projected forward over the prediction window. Only the joint model provides all of these in one model.
| What the prediction needs | Baseline Cox | Time-varying Cox | Landmarking | Joint model |
|---|---|---|---|---|
| Updates as new measurements arrive | ✗ | ✓ | ✓ | ✓ |
| Uses the whole marker history | ✗ | ✗ | ✗ | ✓ |
| Corrects for measurement error | ✗ | ✗ | ✗ | ✓ |
| Valid survival probability for an internal marker | ✓ | ✗ | ✓ | ✓ |
| One coherent model across all prediction times | ✓ | ✓ | ✗ | ✓ |
| Also predicts future marker values | ✗ | ✗ | ✗ | ✓ |
Internal marker: measured on the patient and ending at the event. Landmarking: a separate Cox model at each prediction time, using the last value.
Kalbfleisch JD, Prentice RL. 2nd ed. Wiley 2002. van Houwelingen HC. Scand J Stat 2007; 34: 70–85. Rizopoulos D. Biometrics 2011; 67: 819–829. Rizopoulos D et al. Dynamic predictions with time-dependent covariates using joint modeling and landmarking. arXiv:1306.6479. Putter H, van Houwelingen HC. Landmarking 2.0. arXiv:2103.16252.
Dimitris Rizopoulos: joint models into practice
Software anyone can use, predictions that update per patient, ways to judge and combine them, and their use to schedule clinical decisions.
Rizopoulos D. J Stat Softw 2010; 35(9). Biometrics 2011; 67: 819–829. CRC Press 2012. Rizopoulos D et al. JASA 2014; 109: 1385–1397. Rizopoulos D. J Stat Softw 2016; 72(7). Tomer A et al. Biometrics 2019; 75: 153–162.
Landmarking or joint modelling?
Landmarking
Landmark: a fixed time t at which prediction is made.
Select patients still event-free at t, take their marker value at t, fit a Cox model for the window from t to the horizon u; repeat for each landmark.
Simple and robust to how the marker evolves; uses only the value at t, without measurement error or the shape of the history.
Joint model
One model for the whole marker path and the event; prediction at any t comes from the patient's posterior random effects.
Uses every measurement and its uncertainty, and gives predictions that are coherent across landmarks.
Depends on correct specification of the trajectory and of the link between marker and hazard.
Landmarking is the simple, robust benchmark; the joint model uses the full history and its uncertainty. Reporting both shows how much the marker history adds.
Checking dynamic predictions
A prediction is useful when it ranks patients correctly and when the predicted risks match what happens. Each is checked within the window from the landmark t to the horizon u.
Discrimination
Time-dependent AUC: the chance that a patient with the event in the window was given a higher risk than one without it.
Pr(π̂ᵢ < π̂ⱼ | Tᵢ ∈ (t, u], Tⱼ > u)
Prediction error
Brier score: mean squared gap between predicted event-free probability and observed status.
E[(I(T > u) − π̂(u|t))²]
Calibration
Predicted against observed risk: slope 1 and intercept 0 mean the predictions are right on average.
slope βcal, intercept αcal
Rizopoulos D. Biometrics 2011; 67: 819–829. Steyerberg EW et al. Epidemiology 2010; 21: 128–138.
Where joint models are heading
Many markers, many diseases
Multimorbidity as a network: each hazard driven by several trajectories, each event reshaping several markers.
Feedback by design
Events that change the biomarker path written into the model, rather than absorbed into random-effect variance.
Health-record scale
Partitioned and parallel estimation, so cohorts of a million patients fit in under an hour.
Flexible links
Splines and neural additive terms that reveal thresholds and plateaus while keeping a likelihood and uncertainty bands.
Deep-learning survival
Dynamic-DeepHit and recurrent-network models scale to very large cohorts; joint models keep explicit, interpretable structure and pointwise uncertainty.
Prediction in the clinic
Risk that updates at every visit, built into dashboards and health-record systems for patient-level decisions.
Take-home messages
A repeatedly measured biomarker should not go straight into a Cox model: measurement error, gaps between visits and dropout bias the result.
Joint models fit the marker and the event together through the patient's own random effects, and give predictions that update at every visit.
Two published advances remove the main open issues: jmBIG fits joint models to health-record cohorts of a million patients (BMC Med Res Methodol 2024; 24: 172), and JMbdirect lets events change the marker and risk follow non-linear shapes (BMC Med Res Methodol 2026; 26: 230).
References (1)
Cox DR. Regression models and life-tables. J R Stat Soc B 1972; 34: 187–220.
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. JASA 1958; 53: 457–481.
Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982; 38: 963–974.
Rubin DB. Inference and missing data. Biometrika 1976; 63: 581–592.
Diggle P, Kenward MG. Informative drop-out in longitudinal data analysis. Appl Stat 1994; 43: 49–93.
Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data, 2nd ed. Wiley; 2002.
Prentice RL. Covariate measurement errors and parameter estimation in a failure time regression model. Biometrika 1982; 69: 331–342.
DeGruttola V, Tu XM. Modelling progression of CD4-lymphocyte count and its relationship to survival time. Biometrics 1994; 50: 1003–1014.
Faucett CL, Thomas DC. Simultaneously modelling censored survival data and repeatedly measured covariates: a Gibbs sampling approach. Stat Med 1996; 15: 1663–1685.
Wulfsohn MS, Tsiatis AA. A joint model for survival and longitudinal data measured with error. Biometrics 1997; 53: 330–339.
Henderson R, Diggle P, Dobson A. Joint modelling of longitudinal measurements and event time data. Biostatistics 2000; 1: 465–480.
Tsiatis AA, Davidian M. Joint modeling of longitudinal and time-to-event data: an overview. Stat Sin 2004; 14: 809–834.
Ibrahim JG, Chen MH, Sinha D. Bayesian methods for joint modeling of longitudinal and survival data. Stat Sin 2004; 14: 863–883.
Brown ER, Ibrahim JG, DeGruttola V. A flexible B-spline model for multiple longitudinal biomarkers and survival. Biometrics 2005; 61: 64–73.
References (2)
Chi YY, Ibrahim JG. Joint models for multivariate longitudinal and multivariate survival data. Biometrics 2006; 62: 432–445.
Elashoff RM, Li G, Li N. An approach to joint analysis of longitudinal measurements and competing risks failure time data. Stat Med 2007; 26: 2813–2835.
van Houwelingen HC. Dynamic prediction by landmarking in event history analysis. Scand J Stat 2007; 34: 70–85.
Rizopoulos D. JM: an R package for the joint modelling of longitudinal and time-to-event data. J Stat Softw 2010; 35(9): 1–33.
Rizopoulos D. Dynamic predictions and prospective accuracy in joint models. Biometrics 2011; 67: 819–829.
Rizopoulos D. Joint Models for Longitudinal and Time-to-Event Data. CRC Press; 2012.
Proust-Lima C et al. Joint latent class models for longitudinal and time-to-event data: a review. Stat Methods Med Res 2014; 23: 74–90.
Hickey GL et al. Joint modelling of time-to-event and multivariate longitudinal outcomes. BMC Med Res Methodol 2016; 16: 117.
Hickey GL et al. joineRML: a joint model and software package. BMC Med Res Methodol 2018; 18: 50.
Papageorgiou G et al. An overview of joint modeling of time-to-event and longitudinal outcomes. Annu Rev Stat Appl 2019; 6: 223–240.
Lee C, Yoon J, van der Schaar M. Dynamic-DeepHit. IEEE Trans Biomed Eng 2020; 67: 122–133.
Li S et al. Efficient algorithms for a semiparametric joint model: massive biobank data. Comput Math Methods Med 2022; 1362913.
Bhattacharjee A, Rajbongshi BK, Vishwakarma GK. jmBIG. BMC Med Res Methodol 2024; 24: 172.
Bhattacharjee A. JMbdirect: joint modeling with semi-parametric link functions for bidirectional feedback. BMC Med Res Methodol 2026; 26: 230.
Rizopoulos D, Hatfield LA, Carlin BP, Takkenberg JJM. Combining dynamic predictions using Bayesian model averaging. JASA 2014; 109: 1385–1397.
Rizopoulos D. The R package JMbayes. J Stat Softw 2016; 72(7): 1–46.
Tomer A et al. Personalized schedules for surveillance of low-risk prostate cancer patients. Biometrics 2019; 75: 153–162.
Backup: prediction accuracy of the six models
AUC at 5 years: probability that a patient with the event by year 5 receives a higher predicted risk than one without it.
Integrated Brier score: mean squared difference between predicted survival and observed status, averaged over 0–5 years.
Coverage of 95% intervals: 0.88 for linear without feedback, 0.95 for spline with feedback.
n = 500, competing events, piecewise baseline hazard; means over 1,000 replicates. Blue: no feedback term; orange: feedback term included. Source: Bhattacharjee, BMC Med Res Methodol 2026;26:230, Table 6.
Backup: calibration and comparison in figures
n = 500, competing risks, non-linear true association, moderate feedback, landmark t = 0, horizon u = 5; means over 1,000 replicates with the same train and test splits. Source: Bhattacharjee, BMC Med Res Methodol 2026;26:230, Tables 5 and 9.